Founded in 1880, with seed money from Thomas Edison, Science continues to be at the center of the very best in research across the sciences, with articles that consistently rank among the most cited in the world. Science articles are peer-reviewed, and written to appeal to both scientist and layman. Regular issue features include a news and comment section, book reviews, and coverage of scientific meetings and seminars. The News section features late-breaking news and in-depth news analysis. Compass, an opinion section, publishes letters and commentary by scientists on current science issues. The TechSight section focuses on leading edge techniques and technologies. Topics include: bioinformatics, genome sequencing, and protein sequencing. This section is published in the third issue every month. The Research section features original investigative research and reporting. Other departments include NetWatch, This Week in Science, ScienceScope, Random Samples and New Products.

Established in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.

Industry Dive is a Business news publication that takes a deep dive into 16 of the most competitive industries. Industries included on website: BioPharma, CIO, Construction, Education, Food, Grocery, HR, Healthcare, Marketing, MedTech, Restaurant, Retail, Smart Cities, Supply Chain, Utility, and Waste.

This is the online home for all GenomeWeb LLC outlets. It provides links to newsletter sections. It covers news and trends in the world of genomics which focuses on biotech, science, healthcare and medicine. It includes information on enterprise bioinformatics, high-performance computing, genomic data and database integration, DNA amplification and sequencing, genome assembly and gene prediction. The outlet offers RSS (Really Simple Syndication).

Established in 1981 and written for biotech and biopharma professionals involved in research, technical and commercial management. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues, new products and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups and literature information and articles relating to research projects and the production of biotechnology products.Regular topics in the publication include drug discovery technologies and R&D, trends in instrumentation, genomics and downstream omics, gene therapy, industrial biotechnology, enzymes, bioprocessing strategies, contract manufacture, monoclonal antibodies, bioinformatics, cell culture, LIMS, business issues and regulatory issues.Features the channels: Biobusiness which covers financial, business or patent related; Drug Discovery handles technical issues related to early stages of research and finding new pharmaceuticals; Omics spotlights genomics, proteomics and technologies such as metabolomics and Translational Medicine focuses on clinical and scientific efforts that concerns research and clinical settings. Other sections: Podcasts; Blogs; New Products; Best of the Web; GEN Updates RNAi; Oligonucleotides; Next-Generation Sequencing; Jobs; Classified Mart Marketplace; Real Estate; Conferences/Meetings; and Biotech Companies.The site offers RSS (Really Simple Syndication) and a digital Podcast.The publication DOES accept article submissions. Articles should be submitted to Managing Editor. Articles can be submitted either as POV articles, tutorials, overviews for the Transitional Medicine section, or online. For POV articles, they should be submitted one to two months in advance and should be about 1000 words. For tutorials, the articles should be submitted 4-6 months in advance and should be 1000-12000 words. For the Transitional Medicine section, these articles should be overviews, as opposed to specific points of view. They should also be 1000 words. For the online perspectives, they should be submitted a week before.